AK104 Combined With Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Cervical Cancer.

Keywords: Adverse Drug Reactions; Aminotransferase; Antibodies; Autoimmunity; Blood Proteins; Brachytherapy; Cancer; Cervical Cancer; Clinical Research; Clinical Trials and Studies; Digestive System Diseases and Conditions; Disease Attributes; Disease Attributes - Disease Progression; Disease Progression; Drugs and Therapies; Enzymes and Coenzymes; Gastroenterology; Genetics; Halogens; Health and Medicine; Hepatitis; Immunoglobulins; Immunology; Immunotherapy; Infectious Diseases and Conditions; Iodine; Liver Diseases and Conditions; Oncology; Proteins; Radiotherapy; Surgery; Therapy; Women's Health EN Adverse Drug Reactions Aminotransferase Antibodies Autoimmunity Blood Proteins Brachytherapy Cancer Cervical Cancer Clinical Research Clinical Trials and Studies Digestive System Diseases and Conditions Disease Attributes Disease Attributes - Disease Progression Disease Progression Drugs and Therapies Enzymes and Coenzymes Gastroenterology Genetics Halogens Health and Medicine Hepatitis Immunoglobulins Immunology Immunotherapy Infectious Diseases and Conditions Iodine Liver Diseases and Conditions Oncology Proteins Radiotherapy Surgery Therapy Women's Health 17 17 1 10/16/23 20231016 NES 231016 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Staff editors report on the newly launched clinical trial, NCT06062589, which has the following summary description: "The goal of this study is to determine efficacy and safety of AK104 combined with I-125 brachytherapy for recurrent or metastatic cervical cancer. This is an open-label, single-center, observational study of AK104 with Iodine-125 brachytherapy in the treatment of recurrent or metastatic cervical cancer. [Extracted from the article]

Copyright of Cancer Vaccine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)